Business Description
Medline Inc
NAICS : 325414
SIC : 3841
ISIN : US58507V1070
Share Class Description:
MDLN: Ordinary Shares - Class ATotal Employee Number:
45,000Description
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.12 | |||||
Debt-to-EBITDA | 4.23 | |||||
Interest Coverage | 2.69 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 2.19 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44 | |||||
3-Year EBITDA Growth Rate | 56.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.95 | |||||
9-Day RSI | 65.69 | |||||
14-Day RSI | 57.87 | |||||
3-1 Month Momentum % | -14.33 | |||||
6-1 Month Momentum % | -18.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.41 | |||||
Quick Ratio | 2.51 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 80.21 | |||||
Days Sales Outstanding | 43.75 | |||||
Days Payable | 16.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 11.95 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.86 | |||||
Operating Margin % | 7.08 | |||||
Net Margin % | 3.32 | |||||
EBITDA Margin % | 10.25 | |||||
FCF Margin % | 3.53 | |||||
OCF Margin % | 5.06 | |||||
ROE % | 17.36 | |||||
ROA % | 2.56 | |||||
ROIC % | 5.32 | |||||
ROC (Joel Greenblatt) % | 17.83 | |||||
ROCE % | 5.59 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 52.32 | |||||
Forward PE Ratio | 25.74 | |||||
PE Ratio without NRI | 39.53 | |||||
PS Ratio | 1.25 | |||||
PB Ratio | 2.91 | |||||
Price-to-Free-Cash-Flow | 43.28 | |||||
Price-to-Operating-Cash-Flow | 28.23 | |||||
EV-to-EBIT | 26.07 | |||||
EV-to-Forward-EBIT | 16.8 | |||||
EV-to-EBITDA | 17.18 | |||||
EV-to-Forward-EBITDA | 11.98 | |||||
EV-to-Revenue | 1.76 | |||||
EV-to-Forward-Revenue | 1.39 | |||||
EV-to-FCF | 49.86 | |||||
Earnings Yield (Greenblatt) % | 3.84 | |||||
FCF Yield % | 3.13 |
GF Value™
Medline Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medline Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-31 | In 63 days | ||
| General meeting for 2026 | 2026-06-11 10:00 | 36.54 (+1.33%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 10:40 | 33.80 (+0.84%) | ||
| William Blair 46th Annual Growth Stock Conference | 2026-06-03 15:40 | 33.19 (-4.90%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 09:30 | 45.32 (+2.56%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 45.32 (+2.56%) | ||
| Barclays 28th Annual Global Healthcare Conference | 2026-03-11 09:30 | 42.88 (-1.48%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-25 09:30 | 49.99 (+0.87%) | ||
| Annual report for 2025 | 2026-02-25 | 49.99 (+0.87%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-25 | 49.99 (+0.87%) |
Show
Entries
Guru Commentaries on NAS:MDLN
No articles.
Press Release
Articles on Medline Inc
No articles.
Headlines
See More- 1
Jun 03, 2026
Medline gets FDA warnings over manufacturing issues at Illinois plant
Seeking Alpha • 9:35am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers